observed that, in melanoma patients with low Treg abundance, intratumoral cDC2 density correlates with abundant CD4+ conventional T (Tconv) cells and improved responsiveness to anti‐PD‐1 therapy.[170]. The gene discussed is PDCD1; the disease is melanoma.